Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial

Podobne zapisy

• Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
  od: Holman, R, i wsp.
  Wydane: (2017)
• Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
  od: Mc Morrow, L, i wsp.
  Wydane: (2018)
• Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
  od: Wamil, M, i wsp.
  Wydane: (2020)
• Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
  od: Xu, S, i wsp.
  Wydane: (2019)
• Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
  od: Liam Mc Morrow, i wsp.
  Wydane: (2024-02-01)